altemicidin: sulfamino given in first source; monoterpene alkaloid; isolated from Actinomycete [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 11036174 |
| CHEMBL ID | 3586273 |
| SCHEMBL ID | 1229355 |
| MeSH ID | M0171445 |
| Synonym |
|---|
| 1h-2-pyrindine-7-carboxylic acid, 2,4a,5,6,7,7a-hexahydro-4-(aminocarbonyl)-7-(((aminosulfonyl)acetyl)amino)-6-hydroxy-2-methyl-, (4ar-(4a-alpha,6-beta,7-beta,7a-alpha))- |
| artemicidin |
| brn 4769528 |
| artemicidine |
| altemicidin |
| 125399-82-8 |
| (-)-artemicidine |
| (-)-altemicidin |
| 39e2x82jvd , |
| unii-39e2x82jvd |
| SCHEMBL1229355 |
| CHEMBL3586273 |
| DTXSID20925120 |
| (4ar,6s,7r,7as)-4-carbamoyl-6-hydroxy-2-methyl-7-[(2-sulfamoylacetyl)amino]-4a,5,6,7a-tetrahydro-1h-cyclopenta[c]pyridine-7-carboxylic acid |
| (4ar,6s,7r,7as)-4-(aminocarbonyl)-7-((2-(aminosulfonyl)acetyl)amino)-2,4a,5,6,7,7a-hexahydro-6-hydroxy-2-methyl-1h-cyclopenta(c)pyridine-7-carboxylic acid |
| 1h-2-pyrindine-7-carboxylic acid, 4-(aminocarbonyl)-7-(((aminosulfonyl)acetyl)amino)-2,4a,5,6,7,7a-hexahydro-6-hydroxy-2-methyl-, (4ar-(4a.alpha.,6.beta.,7.beta.,7a.alpha.))- |
| 1h-cyclopenta(c)pyridine-7-carboxylic acid, 4-(aminocarbonyl)-7-((2-(aminosulfonyl)acetyl)amino)-2,4a,5,6,7,7a-hexahydro-6-hydroxy-2-methyl-, (4ar,6s,7r,7as)- |
| 1h-cyclopenta(c)pyridine-7-carboxylic acid, 4-(aminocarbonyl)-7-(((aminosulfonyl)acetyl)amino)-2,4a,5,6,7,7a-hexahydro-6-hydroxy-2-methyl-, (4ar-(4a.alpha.,6.beta.,7.beta.,7a.alpha.))- |
| AKOS040756398 |
Altemicidin is a monoterpene alkaloid.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Altemicidin is a monoterpene alkaloid." | ( Altemicidin, a new acaricidal and antitumor substance. II. Structure determination. Ikeda, D; Kurasawa, S; Naganawa, H; Nakamura, H; Okami, Y; Takahashi, A; Takeuchi, T, 1989) | 2.44 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1230318 | Cytotoxicity against mouse L1210 cells assessed as growth inhibition after 48 hrs by coulter counter analysis | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6 | Natural Product Primary Sulfonamides and Primary Sulfamates. |
| AID1230316 | Toxicity in brine shrimp after 48 hrs | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6 | Natural Product Primary Sulfonamides and Primary Sulfamates. |
| AID1230317 | Acaricidal activity against Tetranychus urticae infected on kidney bean leaves assessed as prevention of infection at 10 ppm after 14 days by green house pot test relative to control | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6 | Natural Product Primary Sulfonamides and Primary Sulfamates. |
| AID1230320 | Acute toxicity in iv dose mouse | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6 | Natural Product Primary Sulfonamides and Primary Sulfamates. |
| AID1849863 | Antiproliferative activity against human IMC cells assessed as inhibition of cell proliferation incubated for 48 hrs by Coulter counter method | 2021 | European journal of medicinal chemistry, Jan-15, Volume: 210 | Chemistry, biosynthesis and biological activity of terpenoids and meroterpenoids in bacteria and fungi isolated from different marine habitats. |
| AID1230319 | Cytotoxicity against mouse invasive mammary carcinoma cells assessed as growth inhibition after 48 hrs by coulter counter analysis | 2015 | Journal of natural products, Jun-26, Volume: 78, Issue:6 | Natural Product Primary Sulfonamides and Primary Sulfamates. |
| AID1849862 | Antiproliferative activity against mouse L1210 cells assessed as inhibition of cell proliferation incubated for 48 hrs by Coulter counter method | 2021 | European journal of medicinal chemistry, Jan-15, Volume: 210 | Chemistry, biosynthesis and biological activity of terpenoids and meroterpenoids in bacteria and fungi isolated from different marine habitats. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.20) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||